Replies to post #190499 on Biotech Values

[DewDiligence]

The drug interaction charts are great.

They are handy reference guides, but Table 4A for HCV-HIV drug interactions could be misleading to some investors who don’t know the HIV arena well.

The DDI between Harvoni and Tenofovir shown in Table 4A applies not just to Tenofovir per se, but also to every one of GILD’s FDCs for HIV: Truvada, Atripla, Stribild, and Complera.